Eagle Pharmaceuticals Stock Price on August 28, 2020
| EGRX Stock | USD 4.48 0.09 2.05% |
Below is the normalized historical share price chart for Eagle Pharmaceuticals extending back to February 12, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eagle Pharmaceuticals stands at 4.48, as last reported on the 18th of April 2024, with the highest price reaching 4.75 and the lowest price hitting 4.36 during the day.
If you're considering investing in Eagle Stock, it is important to understand the factors that can impact its price. We consider Eagle Pharmaceuticals moderately volatile. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0201, which denotes the company had a 0.0201% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Eagle Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Eagle Pharmaceuticals' Mean Deviation of 4.19, downside deviation of 5.15, and Coefficient Of Variation of 5897.51 to check if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Eagle Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.06 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 138 M in 2024. . At this time, Eagle Pharmaceuticals' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 7.07 in 2024, whereas Price To Sales Ratio is likely to drop 1.30 in 2024. Eagle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 2014 | 200 Day MA 10.8319 | 50 Day MA 5.5425 | Beta 0.409 |
Eagle |
Sharpe Ratio = 0.0201
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | EGRX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.32 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Eagle Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eagle Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.236 | Enterprise Value Ebitda 2.0711 | Price Sales 0.2309 | Shares Float 10.4 M | Wall Street Target Price 17 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Eagle Pharmaceuticals Stock history
Eagle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eagle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eagle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eagle Pharmaceuticals stock prices may prove useful in developing a viable investing in Eagle Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15 M | 14.9 M | |
| Net Income Applicable To Common Shares | 41 M | 24.6 M |
Eagle Pharmaceuticals Quarterly Net Working Capital |
|
Eagle Pharmaceuticals Stock Technical Analysis
Eagle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eagle Pharmaceuticals Period Price Range
Eagle Pharmaceuticals April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Eagle Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eagle Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eagle Pharmaceuticals stock market strength indicators, traders can identify Eagle Pharmaceuticals entry and exit signals to maximize returns
Eagle Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eagle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eagle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eagle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0195 | |||
| Jensen Alpha | 0.0141 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0066 | |||
| Treynor Ratio | 0.0553 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eagle Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Eagle Stock analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Eagle Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.85 | Revenue Per Share 19.684 | Quarterly Revenue Growth (0.13) | Return On Assets 0.0663 |
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.